These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38116528)

  • 61. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms.
    Chi L; Tu P; Ru H; Lu K
    Gut Microbes; 2021; 13(1):1921912. PubMed ID: 34313531
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics.
    Abdelsalam NA; Ramadan AT; ElRakaiby MT; Aziz RK
    Front Pharmacol; 2020; 11():390. PubMed ID: 32372951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predicting drug-microbiome interactions with machine learning.
    McCoubrey LE; Gaisford S; Orlu M; Basit AW
    Biotechnol Adv; 2022; 54():107797. PubMed ID: 34260950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice.
    Lim JJ; Li X; Lehmler HJ; Wang D; Gu H; Cui JY
    Toxicol Sci; 2020 Sep; 177(1):168-187. PubMed ID: 32544245
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacterial community structure alterations within the colorectal cancer gut microbiome.
    Loftus M; Hassouneh SA; Yooseph S
    BMC Microbiol; 2021 Mar; 21(1):98. PubMed ID: 33789570
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microbiome-Linked Crosstalk in the Gastrointestinal Exposome towards Host Health and Disease.
    Moon Y
    Pediatr Gastroenterol Hepatol Nutr; 2016 Dec; 19(4):221-228. PubMed ID: 28090466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deciphering Gut Microbiome Responses upon Microplastic Exposure via Integrating Metagenomics and Activity-Based Metabolomics.
    Tu P; Xue J; Niu H; Tang Q; Mo Z; Zheng X; Wu L; Chen Z; Cai Y; Wang X
    Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110188
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Gut Bacterial Enzymes for Keto-Reductive Metabolism of Xenobiotics.
    Qian L; Ouyang H; Gordils-Valentin L; Hong J; Jayaraman A; Zhu X
    ACS Chem Biol; 2022 Jul; 17(7):1665-1671. PubMed ID: 35687750
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two Apriona Species Sharing a Host Niche Have Different Gut Microbiome Diversity.
    Zhang SK; Wang Y; Li ZK; Xue HJ; Zhou XD; Huang JH
    Microb Ecol; 2022 May; 83(4):1059-1072. PubMed ID: 34302194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease.
    Lazarević S; Đanic M; Al-Salami H; Mooranian A; Mikov M
    Front Pharmacol; 2022; 13():879170. PubMed ID: 35450035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advanced Approaches to Model Xenobiotic Metabolism in Bacterial Genotoxicology In Vitro.
    Oda Y
    Adv Biochem Eng Biotechnol; 2017; 157():97-134. PubMed ID: 27619490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of drugs with gut microbiota modulators.
    Kim DH
    Drug Metab Rev; 2023 Aug; 55(3):181-194. PubMed ID: 36999361
    [TBL] [Abstract][Full Text] [Related]  

  • 76. BioTransformer 3.0-a web server for accurately predicting metabolic transformation products.
    Wishart DS; Tian S; Allen D; Oler E; Peters H; Lui VW; Gautam V; Djoumbou-Feunang Y; Greiner R; Metz TO
    Nucleic Acids Res; 2022 Jul; 50(W1):W115-W123. PubMed ID: 35536252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome.
    Farag MA; Hegazi NM; Donia MS
    Metabolomics; 2020 Aug; 16(8):86. PubMed ID: 32748036
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction of Intestinal Microbiota with Medications.
    Liu M; Xu J; Jin Q; Li Y
    Curr Drug Metab; 2023; 24(8):554-567. PubMed ID: 37073652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ecology-guided prediction of cross-feeding interactions in the human gut microbiome.
    Goyal A; Wang T; Dubinkina V; Maslov S
    Nat Commun; 2021 Feb; 12(1):1335. PubMed ID: 33637740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Obesity influences the microbiotic biotransformation of chlorogenic acid.
    Mortelé O; Xavier BB; Lammens C; Malhotra-Kumar S; Jorens PG; Dirinck E; van Nuijs ALN; Hermans N
    J Pharm Biomed Anal; 2022 Mar; 211():114550. PubMed ID: 35124448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.